Demyelinating diseases and potential repair strategies.
Demyelination is associated with a number of neurological disorders including multiple sclerosis (MS), spinal cord injury and nerve compression. MS lesions often show axon loss and therefore reparative therapeutic goals include remyelination and neuroprotection of vulnerable axons. Experimental cellular transplantation has proven successful in a number of demyelination and injury models to remyelinate and improve functional outcome. Here we discuss the remyelination and neuroprotective potential of several myelin-forming cells types and their behavior in different demyelination and injury models. Better understanding of these models and current cell-based strategies for remyelination and neuroprotection offer exciting opportunities to develop strategies for clinical studies.
Radtke
C
C
Department of Neurology, Yale University School of Medicine, New Haven, CT 06516, USA.
Spies
M
M
Sasaki
M
M
Vogt
P M
PM
Kocsis
J D
JD
D000818:Animals; D017690:Cell Transplantation / Q000379:methods*; D003711:Demyelinating Diseases / Q000628:therapy*; D004195:Disease Models, Animal; D006801:Humans; D009186:Myelin Sheath / Q000502:physiology*; D009416:Nerve Regeneration / Q000502:physiology